S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
NYSE:PFE

Pfizer - PFE Short Interest Ratio & Short Volume

$43.76
-0.40 (-0.91%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$43.73
$44.61
50-Day Range
$43.76
$52.30
52-Week Range
$40.94
$61.71
Volume
22.96 million shs
Average Volume
16.69 million shs
Market Capitalization
$245.60 billion
P/E Ratio
8.56
Dividend Yield
3.62%
Price Target
$57.00

Pfizer Short Interest Data

Current Short Volume
63,890,000 shares
Previous Short Volume
62,200,000 shares
Change Vs. Previous Month
+2.72%
Dollar Volume Sold Short
$2.94 billion
Short Interest Ratio / Days to Cover
3.6
Last Record Date
September 15, 2022
Outstanding Shares
5,612,350,000 shares
Percentage of Shares Shorted
1.14%
Today's Trading Volume
22,962,293 shares
Average Trading Volume
16,688,389 shares
Today's Volume Vs. Average
37.59%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Pfizer ?

Sign up to receive the latest short interest report for Pfizer and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PFE Short Interest Over Time

PFE Days to Cover Over Time

PFE Percentage of Float Shorted Over Time


Pfizer (NYSE:PFE) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/202263,890,000 shares $2.94 billion +2.7%N/A3.6 $45.94
8/31/202262,200,000 shares $2.81 billion -8.5%N/A3.3 $45.23
8/15/202267,940,000 shares $3.38 billion +13.4%N/A3.4 $49.75
7/31/202259,900,000 shares $3.03 billion -11.1%N/A2.9 $50.51
7/15/202267,350,000 shares $3.49 billion -2.3%N/A3 $51.75
6/30/202268,930,000 shares $3.61 billion -10.5%N/A2.9 $52.43
6/15/202276,980,000 shares $3.73 billion -0.3%N/A3.1 $48.51
5/31/202277,200,000 shares $4.09 billion +33.9%N/A2.9 $53.04
5/15/202257,670,000 shares $2.88 billion -15.2%N/A2.1 $49.92
4/30/202267,990,000 shares $3.34 billion +8.5%N/A2.3 $49.07
4/15/202262,650,000 shares $3.33 billion +1.8%N/A2 $53.12
3/31/202261,560,000 shares $3.19 billion +0.6%N/A1.9 $51.77
3/15/202261,180,000 shares $3.19 billion -6.8%N/A1.7 $52.21
2/28/202265,640,000 shares $3.08 billion +3.8%N/A1.7 $46.94
2/15/202263,260,000 shares $3.15 billion -8.6%N/A1.5 $49.79
1/31/202269,220,000 shares $3.65 billion +8.0%N/A1.6 $52.69
1/15/202264,080,000 shares $3.52 billion +9.3%N/A1.5 $54.95
12/31/202158,640,000 shares $3.46 billion -11.2%N/A1.4 $59.05
12/15/202166,010,000 shares $3.88 billion +3.9%N/A1.7 $58.80
11/30/202163,560,000 shares $3.42 billion +0.0%N/A1.9 $53.73
11/15/202163,540,000 shares $3.15 billion +7.9%N/A2.1 $49.65
10/29/202158,880,000 shares $2.58 billion +8.1%N/A1.7 $43.74
10/15/202154,480,000 shares $2.26 billion +4.4%N/A1.7 $41.49
9/30/202152,180,000 shares $2.24 billion -3.5%N/A1.6 $43.01
9/15/202154,090,000 shares $2.42 billion -7.8%N/A1.7 $44.77
8/31/202158,670,000 shares $2.70 billion -4.5%N/A1.9 $46.07
8/13/202161,420,000 shares $2.98 billion +12.7%N/A2.1 $48.48
7/30/202154,500,000 shares $2.33 billion -11.0%1.0%2.1 $42.81
7/15/202161,240,000 shares $2.46 billion -3.0%N/A2.5 $40.09
6/30/202163,150,000 shares $2.47 billion +5.7%N/A2.4 $39.16
6/15/202159,770,000 shares $2.37 billion +1.3%N/A2.2 $39.59
5/28/202159,000,000 shares $2.29 billion +2.9%N/A2.2 $38.73
5/14/202157,320,000 shares $2.30 billion -1.2%N/A2 $40.10
4/30/202158,020,000 shares $2.24 billion -4.7%N/A1.9 $38.60
4/15/202160,890,000 shares $2.26 billion -7.6%N/A1.9 $37.17
3/31/202165,930,000 shares $2.38 billion -3.5%N/A2 $36.11
3/15/202168,320,000 shares $2.39 billion +1.0%N/A2 $34.94
2/26/202167,650,000 shares $2.29 billion +7.2%N/A1.7 $33.82
2/12/202163,120,000 shares $2.17 billion +0.0%N/A1.5 $34.43
1/29/202163,110,000 shares $2.26 billion -3.6%N/A1.3 $35.86













PFE Short Interest - Frequently Asked Questions

What is Pfizer's current short interest?

Short interest is the volume of Pfizer shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 63,890,000 shares of PFE short. Learn More on Pfizer's current short interest.

What is a good short interest ratio for Pfizer?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PFE shares currently have a short interest ratio of 4.0. Learn More on Pfizer's short interest ratio.

Which institutional investors are shorting Pfizer?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pfizer: Goldman Sachs Group Inc., Nomura Holdings Inc., Centiva Capital LP, Parallax Volatility Advisers L.P., Jane Street Group LLC, Wolverine Trading LLC, Apollo Management Holdings L.P., CSS LLC IL, Capital Markets Trading UK LLP, Caption Management LLC, Capula Management Ltd, Delta Accumulation LLC, Parallax Volatility Advisers L.P., Point72 Hong Kong Ltd, Cubist Systematic Strategies LLC, Citadel Advisors LLC, Symmetry Peak Management LLC, Laurion Capital Management LP, Millennium Management LLC, Nomura Holdings Inc., Concourse Financial Group Securities Inc., Wells Fargo & Company MN, Allianz Asset Management GmbH, Natixis, PEAK6 Investments LLC, Marathon Trading Investment Management LLC, BNP Paribas Arbitrage SA, Group One Trading L.P., Twin Tree Management LP, UBS Group AG, Bank of Montreal Can, JPMorgan Chase & Co., Walleye Trading LLC, Credit Agricole S A, IMC Chicago LLC, Clear Street Markets LLC, QVR LLC, US Bancorp DE, SG Americas Securities LLC, XR Securities LLC, FNY Investment Advisers LLC, CenterStar Asset Management LLC, and CTC LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Pfizer's short interest increasing or decreasing?

Pfizer saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 63,890,000 shares, an increase of 2.7% from the previous total of 62,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Pfizer's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Pfizer: AbbVie Inc. (0.73%), Merck & Co., Inc. (0.77%), Eli Lilly and Company (0.63%), Bristol-Myers Squibb (1.08%), Zoetis Inc. (0.90%), Johnson & Johnson (0.54%), Novo Nordisk A/S (0.18%), Abbott Laboratories (0.92%), AstraZeneca PLC (0.21%), and Novartis AG (0.25%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($4.11 billion), Canadian Natural Resources Limited ($3.64 billion), Charter Communications, Inc. ($3.15 billion), Lucid Group, Inc. ($2.09 billion), Chesapeake Energy Co. ($2.02 billion), Coinbase Global, Inc. ($2.01 billion), T. Rowe Price Group, Inc. ($1.92 billion), Plug Power Inc. ($1.77 billion), Rivian Automotive, Inc. ($1.71 billion), and Williams-Sonoma, Inc. ($1.59 billion). View all of the most shorted stocks.

What does it mean to sell short Pfizer stock?

Short selling PFE is an investing strategy that aims to generate trading profit from Pfizer as its price is falling. PFE shares are trading down $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Pfizer?

A short squeeze for Pfizer occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PFE, which in turn drives the price of the stock up even further.

How often is Pfizer's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PFE, twice per month. The most recent reporting period available is September, 15 2022.



This page (NYSE:PFE) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.